Wealthstreet Investment Advisors’s AbbVie ABBV Stock Holding History

Wealthstreet Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-34,175	Closed	-$3.7M	–	95
2021 Q1	$3.7M	Buy	34,175 +620	+2%	+$66.3K	0.36%	70
2020 Q4	$3.6M	Buy	33,555 +50	+0.1%	+$4.8K	0.36%	68
2020 Q3	$2.94M	Buy	33,505 +1,875	+6%	+$177K	0.33%	71
2020 Q2	$3.1M	Buy	31,630 +4,193	+15%	+$369K	0.38%	64
2020 Q1	$2.09M	Hold	27,437	–	–	0.31%	82
2019 Q4	$2.43M	Hold	27,437	–	–	0.28%	84
2019 Q3	$2.15M	Hold	27,437	–	–	0.28%	87
2019 Q2	$2M	Sell	27,437 -100	-0.4%	-$7.86K	0.26%	96
2019 Q1	$2.22M	Hold	27,537	–	–	0.29%	85
2018 Q4	$2.12M	Sell	27,537 -1,400	-5%	-$123K	0.3%	82
2018 Q3	$2.74M	Hold	28,937	–	–	0.34%	72
2018 Q2	$2.68M	Sell	28,937 -700	-2%	-$68.4K	0.35%	73
2018 Q1	$2.81M	Buy	29,637 +551	+2%	+$60.5K	0.35%	69
2017 Q4	$2.81M	Buy	+29,086	New	+$2.74M	0.34%	73

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $299B AUM 27.55% 1-Year Est. Return

Wealthstreet Investment Advisors's ABBV Position: Q2 2021 in Review

Wealthstreet Investment Advisors sold out of AbbVie (ABBV) in Q2 2021, closing a stake of 34,175 shares — an estimated $3.7M sold.

Wealthstreet Investment Advisors first reported a position in ABBV in Q4 2017 and held it in 14 quarters. The position peaked at $3.7M in Q1 2021. 2,677 funds tracked by Wall St. Rank hold ABBV as of Q2 2021.

Wealthstreet Investment Advisors reported no remaining AbbVie position as of Q2 2021 after selling out during the quarter.
Wealthstreet Investment Advisors sold 34,175 AbbVie shares in Q2 2021, an estimated $3.7M.
Wealthstreet Investment Advisors first reported a position in AbbVie in Q4 2017 and held it in 14 quarters.
Wealthstreet Investment Advisors's AbbVie position peaked at $3.7M in Q1 2021.
2,677 funds tracked by Wall St. Rank held AbbVie as of Q2 2021.

Based on Wealthstreet Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.